Incidencia y prevalencia
MG: miastenia gravis; UNM: unión neuromuscular; anti-AChR: anticuerpos contra el receptor de acetilcolina
Sathasivam, S. Diagnosis and management of myasthenia gravis. Prog Neurol Psychiatry; 2014;18:6–14. Gilhus NE, et al. Myasthenia gravis. Nat Rev Dis primers ; 2019;5(1):30. Sanders, et al. The Duke myasthenia gravis clinic registry: Description and demographics. Muscle & Nerve; 2020;63(2):209–216. Myasthenia Gravis [Internet]. National Organization for Rare Disorders. 2015 [citado el 9 de noviembre de 2023]. Disponible en: https://rarediseases.org/rare-diseases/myasthenia-gravis/ Berrih–Aknin S, Le Panse R. Myasthenia gravis: A comprehensive review of immune dysregulation and etiological mechanisms. J Autoimmun; 2014;52:90–100. Gilhus NE, et al. Myasthenia Gravis and infectious disease. J Neurol; 2018;265(6):1251–1258. Dresser L, et al. Myasthenia gravis: Epidemiology, pathophysiology and clinical manifestations. J Clin Med; 2021;10(11):2235. Beloor Suresh A, Asuncion RMD. Myasthenia Gravis. [Actualizado 8 de agosto de 2023]. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK559331/ advance Soy un profesional sanitario registrado en España No soy un
profesional sanitario